Works about LINAGLIPTIN

Results: 128

Diosmin Potentiates the Antidiabetic Effects of Linagliptin in Nicotinamide/Streptozotocin-Induced Diabetic Wistar Rats.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 656, doi. 10.3390/ph18050656

By:

Abbas, Eman B.;
El-Kalaawy, Asmaa M.;
Ahmed, Noha A.;
Shams, Anwar;
Khaliefa, Amal K.;
Ahmed, Osama M.

Publication type:

Article

Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 9, p. 2136, doi. 10.1093/ckj/sfab104

By:

Wanner, Christoph;
Cooper, Mark E;
Johansen, Odd Erik;
Toto, Robert;
Rosenstock, Julio;
McGuire, Darren K;
Kahn, Steven E;
Pfarr, Egon;
Schnaidt, Sven;
Eynatten, Maximilian von;
George, Jyothis T;
Gollop, Nicholas D;
Marx, Nikolaus;
Alexander, John H;
Zinman, Bernard;
Perkovic, Vlado

Publication type:

Article

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.

Published in:

Clinical Kidney Journal, 2021, v. 14, p. 226, doi. 10.1093/ckj/sfaa225

By:

Wanner, Christoph;
Cooper, Mark E;
Johansen, Odd Erik;
Toto, Robert;
Rosenstock, Julio;
McGuire, Darren K;
Kahn, Steven E;
Pfarr, Egon;
Schnaidt, Sven;
Eynatten, Maximilian von;
George, Jyothis T;
Gollop, Nicholas D;
Marx, Nikolaus;
Alexander, John H;
Zinman, Bernard;
Perkovic, Vlado;
investigators, the CARMELINA

Publication type:

Article

A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19.

Published in:

Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.794382

By:

Abuhasira, Ran;
Ayalon-Dangur, Irit;
Zaslavsky, Neta;
Koren, Ronit;
Keller, Mally;
Dicker, Dror;
Grossman, Alon

Publication type:

Article

Spectrophotometric estimation of linagliptin using ion-pair complexation and oxidative coupling reactions - A green approach.

Published in:

Thai Journal of Pharmaceutical Sciences, 2020, v. 44, n. 4, p. 245

By:

Gurrala, Sunitha;
Anumolu, Panikumar Durga;
Menkana, Sahitya;
Gandla, Nikitha;
Toddi, Keerthi

Publication type:

Article

Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy.

Published in:

Computational Intelligence & Neuroscience, 2022, v. 2022, p. 1, doi. 10.1155/2022/4272520

By:

Zhang, Panke;
Meng, Jingxi;
Duan, Mingliang;
Li, Dan;
Wang, Ruixin

Publication type:

Article

Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart.

Published in:

Chemical Biology & Drug Design, 2023, v. 102, n. 5, p. 1085, doi. 10.1111/cbdd.14308

By:

Doğanyiğit, Züleyha;
Okan, Aslı;
Taheri, Serpil;
Yılmaz, Zeynep;
Akyüz, Enes;
Demir, Necdet

Publication type:

Article

Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia.

Published in:

Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2024, v. 77, n. 2, p. 1, doi. 10.4212/cjhp.3534

By:

Dobson, Raea

Publication type:

Article

Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition.

Published in:

Molecular & Cellular Biochemistry, 2022, v. 477, n. 4, p. 995, doi. 10.1007/s11010-021-04349-1

By:

Pei, Biwei;
Zhang, Na;
Pang, Tingting;
Sun, Gengyun

Publication type:

Article

New enantioselective liquid chromatography method development and validation of dipeptidyl peptidase IV inhibitors using a macrocyclic glycopeptide (vancomycin) chiral stationary phase under polar ionic mode condition.

Published in:

Chirality, 2022, v. 34, n. 7, p. 989, doi. 10.1002/chir.23448

By:

Arnipalli, Manikanta Swamy;
Nimmu, Narendra varma;
Boddapati, S. N. Murthy;
Challa, Gangu Naidu;
Jaweria, Syed;
Kola, A. Emmanuel

Publication type:

Article

Novel UV Spectroscopic Methods for Simultaneous Assessment of Empagliflozin, Linagliptin and Metformin in Ternary Mixture.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2022, v. 56, p. S669, doi. 10.5530/ijper.56.4s.213

By:

Sen, Ashim Kumar;
Pandey, Harshita;
Maheshwari, Rajesh A.;
Zanwar, Aarti Sachin;
Velmurugan, Ramaswamy;
Sen, Dhanya B.

Publication type:

Article

Determination of Nitazoxanide in Biological Matrices by LC-MS/MS Technique: Method Development and Validation.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2022, v. 56, n. 2, p. 539, doi. 10.5530/ijper.56.2.76

By:

Mohammad, Abdul Saleem;
Jayanthi, B.

Publication type:

Article

Design of Experiments for Critical Material Attributes Assessment of Linagliptin and Metformin Fixed-dose Combination Tablets.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2021, v. 55, n. 3, p. 701, doi. 10.5530/ijper.55.3.142

By:

Kang Min Kim

Publication type:

Article

An analytical of an experimental method for evaluation and validation from measuring dissolution of Metformin and Empagliflozin for generic tablets: Confirmation the results by docking method.

Published in:

Revista Colombiana de Ciencias Químico-Farmacéuticas, 2024, v. 53, n. 3, p. 905, doi. 10.15446/rcciquifa.v53n3.119242

By:

Dehghandar, Motahareh;
Latifi, Parisa;
Shahriari, Sara;
Mollaamin, Fatemeh;
Eskandary, Iman;
Monajjemi, Majid

Publication type:

Article

Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04511-1

By:

Guardado-Mendoza, Rodolfo;
Garcia-Magaña, Miguel Angel;
Martínez-Navarro, Liz Jovanna;
Macías-Cervantes, Hilda Elizabeth;
Aguilar-Guerrero, Rodolfo;
Suárez-Pérez, Erick L.;
Aguilar-García, Alberto

Publication type:

Article

Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94896-w

By:

Fushimi, Yoshiro;
Obata, Atsushi;
Sanada, Junpei;
Nogami, Yuka;
Ikeda, Tomoko;
Yamasaki, Yuki;
Obata, Yoshiyuki;
Shimoda, Masashi;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Article

Pharmacokinetics and Bioequivalence of Single‐Oral‐Dose Linagliptin: A Randomized, 2‐Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1157, doi. 10.1002/cpdd.1104

By:

Li, Yan;
Zhang, Xueyuan;
Qi, Lu;
Tong, Yuanxu;
Bai, Haihong;
Liu, Ju;
Liu, Ying;
Chen, Youli;
Wang, Xinghe

Publication type:

Article

Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1275730

By:

Jalal, Israa A.;
Elkhoely, Abeer;
Mohamed, Shimaa K.;
Ahmed, Amany A. E.

Publication type:

Article

Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985

By:

Hong, Jun Hwa;
Kim, Myung Jin;
Min, Kyung Wan;
Won, Jong Chul;
Kim, Tae Nyun;
Lee, Byung‐Wan;
Kang, Jun Goo;
Kim, Jae Hyeon;
Park, Jung Hwan;
Ku, Bon Jeong;
Lee, Chang Beom;
Kim, Sang Yong;
Shon, Ho Sang;
Lee, Woo Je;
Park, Joong‐Yeol

Publication type:

Article

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5013, doi. 10.1111/dom.15915

By:

Ren, Qian;
Li, Ling;
Su, Xiuhai;
Hu, Xiaolin;
Qin, Guijun;
Han, Jie;
Liu, Yu;
Wang, Junmin;
Ji, Linong

Publication type:

Article

Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3064, doi. 10.1111/dom.15180

By:

Laursen, Jens Christian;
Rotbain Curovic, Viktor;
Kroonen, Marjolein Y. A. M.;
Jongs, Niels;
Zobel, Emilie H.;
Hansen, Tine W.;
Frimodt‐Møller, Marie;
Laverman, Gozewijn D.;
Kooy, Adriaan;
Persson, Frederik;
Heerspink, Hiddo J. L.;
Hansen, Christian Stevns;
Rossing, Peter

Publication type:

Article

Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1453, doi. 10.1111/dom.14991

By:

Rosenstock, Julio;
Kolkailah, Ahmed A.;
McGuire, Darren K.;
Espeland, Mark A.;
Mattheus, Michaela;
Pfarr, Egon;
Lund, Søren S.;
Marx, Nikolaus

Publication type:

Article

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636

By:

Meier, Juris J.;
Quast, Daniel R.;
Nauck, Michael A.;
Schenker, Nina;
Deacon, Carolyn F.;
Holst, Jens J.;
Plum‐Mörschel, Leona;
Kapitza, Christoph

Publication type:

Article

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557

By:

Muskiet, Marcel H. A.;
Tonneijck, Lennart;
Smits, Mark M.;
Kramer, Mark H. H.;
Ouwens, D. Margriet;
Hartmann, Bolette;
Holst, Jens J.;
Danser, A. H. Jan;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

Article

Urinary dipeptidyl peptidase‐4 protein is increased by linagliptin and is a potential predictive marker of urine albumin‐to‐creatinine ratio reduction in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1968, doi. 10.1111/dom.14407

By:

Klein, Thomas;
Tammen, Harald;
Mark, Michael;
Benetti, Elisa;
Delić, Denis;
Schepers, Cornelia;
Eynatten, Maximilian

Publication type:

Article

Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1208, doi. 10.1111/dom.14317

By:

Bae, Jaehyun;
Song, Kee‐Ho;
Park, Jong Suk;
Lee, Jae Hyuk;
Jeong, In‐Kyung;
Kim, Hyun Jin;
Lim, Young‐Hyo;
Cho, Jae‐Hyoung;
Choi, Sung Hee;
Chung, Yoon‐Sok;
Kang, Eun Seok

Publication type:

Article

Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 832, doi. 10.1111/dom.14263

By:

Komorizono, Yasuji;
Hosoyamada, Kaori;
Imamura, Naoko;
Kajiya, Shoko;
Hashiguchi, Yasuhiro;
Ueyama, Norio;
Shinmaki, Hirohiko;
Koriyama, Nobuyuki;
Tsukasa, Masako;
Kamada, Tetsuro

Publication type:

Article

Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254

By:

Espeland, Mark A.;
Pratley, Richard E.;
Rosenstock, Julio;
Kadowaki, Takashi;
Seino, Yutaka;
Zinman, Bernard;
Marx, Nikolaus;
McGuire, Darren K.;
Andersen, Knut Robert;
Mattheus, Michaela;
Keller, Annett;
Weber, Maria;
Johansen, Odd Erik

Publication type:

Article

Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 642, doi. 10.1111/dom.14231

By:

Yang, Wenying;
Xu, Xiangjin;
Lei, Tao;
Ma, Jianhua;
Li, Ling;
Shen, Jie;
Ye, Binqi;
Zhu, Sandy;
Meinicke, Thomas

Publication type:

Article

CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial.

Published in:

Perspectives in Clinical Research, 2020, v. 11, n. 1, p. 44, doi. 10.4103/picr.PICR_157_19

By:

Nath, Baishali;
Suvarna, Viraj

Publication type:

Article

Treatment With Evogliptin for Type 2 Diabetes Effectiveness and Safety.

Published in:

Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2023, v. 14, n. 5, p. 8

By:

Khan, Kamran

Publication type:

Article

Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study.

Published in:

Hormone Molecular Biology & Clinical Investigation, 2023, v. 44, n. 4, p. 385, doi. 10.1515/hmbci-2022-0070

By:

Zamani, Batool;
Tabatabizadeh, Seyyed Mashaalah;
Gilasi, Hamidreza;
Yazdani, Shadi

Publication type:

Article

Formulation and Evaluation of Floating Polymeric Nanoparticles of Linagliptin in Capsules.

Published in:

Journal of Young Pharmacists, 2020, v. 12, p. s32, doi. 10.5530/jyp.2020.12s.43

By:

Prasanthi, D.;
Kumari, J. Krishna;
Hymavathi, S.

Publication type:

Article

Linagliptin in combination with insulin suppresses apoptotic unfolded protein response in ovaries exposed to type 1 diabetes.

Published in:

Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3898

By:

Okan, Aslı;
Demir, Necdet;
Doğanyiğit, Züleyha

Publication type:

Article

Validated Method Development For The Simultaneous Estimation Of Empagliflozin, Linagliptin, And Metformin In Marketed Formulation Using Uv Vis Spectrophotometer.

Published in:

International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 4, p. 5300, doi. 10.31838/ijpr/2020.12.04.702

By:

BAOKAR, SHRIKRISHNA;
PATIL, RAJENDRA;
PANDEY, ADITYA NATH

Publication type:

Article

Comparative Effectiveness of Glimepiride versus Linagliptin as add-on to Metformin in Type-2-Diabetes Mellitus.

Published in:

Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 6, p. 95, doi. 10.22270/jddt.v13i6.5879

By:

Awofisayo, Sunday Olajide;
Akwaowoh, Akpabio Elijah;
Arhewoh, Matthew Ikhuoria;
Akpakpan, Goodluck Sunday

Publication type:

Article

Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA.

Published in:

Journal of Analytical Methods in Chemistry, 2019, p. 1, doi. 10.1155/2019/7534609

By:

Heleno Ferreira, Raquel Balestri;
Duarte, Jonathaline Apollo;
Ferreira, Flávio Dias;
Oliveira, Luis Flávio Souza de;
Machado, Michel Mansur;
Malesuik, Marcelo Donadel;
Paula, Fávero Reisdorfer;
Steppe, Martin;
Schapoval, Elfrides Eva Shermann;
Paim, Clésio Soldateli

Publication type:

Article

Efficacy and Safety of Linagliptin and Insulin in Patients of Type 2 Diabetes Mellitus with Grade 3-5 Chronic Kidney Disease in a Tertiary Care Hospital.

Published in:

Journal of Clinical & Diagnostic Research, 2021, v. 15, n. 8, p. 12, doi. 10.7860/JCDR/2021/50693.15204

By:

HAMEED, SAAJID;
KUMAR, PANKAJ;
PRAKASH, VED;
KUMAR, MANISH;
DIKSHIT, HARIHAR

Publication type:

Article

Graphene oxide modified glassy carbon electrode for determination of linagliptin in dosage form, biological fluids, and rats' feces using square wave voltammetry.

Published in:

Arabian Journal of Chemistry, 2022, v. 15, n. 3, p. N.PAG, doi. 10.1016/j.arabjc.2021.103663

By:

Haredy, Ahmed M.;
Derayea, Sayed M.;
Gahlan, Ahmed A.;
Omar, Mahmoud A.;
Saleh, Gamal A.

Publication type:

Article

Mechanism of Linagliptin on Stromal Cell-Derived Factor 1 and Vascular Endothelial Growth Factor Protein after Molar Pulp Revascularization in Rats.

Published in:

Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 2, p. 634, doi. 10.36468/pharmaceutical-sciences.1317

By:

YE ZHOU;
YONGJING LIU;
XIAOWEN LU

Publication type:

Article

New-Onset Atrial Fibrillation After Exenatide Injection: Coincidence or Consequence?

Published in:

Endocrinology Research & Practice, 2023, v. 27, n. 4, p. 241, doi. 10.5152/erp.2023.23262

By:

Yamantürk, Yakup Yunus;
Esenboğa, Kerim;
Yılmaz, Gözde Cansu;
Baskovski, Emir;
Candemir, Başar;
Şahin, Mustafa

Publication type:

Article

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.

Published in:

Renal Failure, 2023, v. 45, n. 1, p. 1, doi. 10.1080/0886022X.2023.2194434

By:

Fayed, Ahmed;
Hammad, Ahmed A.;
Abdulazim, Dina O.;
Hammad, Hany;
Amin, Mohamed;
Elhadidy, Samir;
Salem, Mona M.;
ElAzim, Ibrahim M. Abd;
Zsom, Lajos;
Csongradi, Eva;
Soliman, Karim M.;
Sharaf El Din, Usama A.

Publication type:

Article

Synergistic Antitumor and Apoptotic Activity of Sitagliptin or Linagliptin Plus Cisplatin Against A549 Lung Cancer Cells (An Invitro Study).

Published in:

Journal of Contemporary Medical Sciences, 2024, v. 10, n. 3, p. 228, doi. 10.22317/jcms.v10i3.1555

By:

Al Khafaji, Ameer M.;
Bairam, Ahsan F.

Publication type:

Article

The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis.

Published in:

Journal of Drug Targeting, 2023, v. 31, n. 6, p. 646, doi. 10.1080/1061186X.2023.2216894

By:

Liu, Jing;
Liu, Zhihong;
Lu, Ming;
Zhang, Yanrong

Publication type:

Article

Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose.

Published in:

Oral Diseases, 2024, v. 30, n. 7, p. 4195, doi. 10.1111/odi.14893

By:

Wang, Hongyu;
She, Xiao;
Xu, Qiongdong;
Zhou, Xingyu;
Tang, Qinchao;
Wei, Huakun;
Huang, Tianjing;
Liang, Feixin

Publication type:

Article

Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice.

Published in:

Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.944323

By:

Nirwan, Nikita;
Vohora, Divya

Publication type:

Article

Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice.

Published in:

Drug Discoveries & Therapeutics, 2020, v. 14, n. 5, p. 218, doi. 10.5582/ddt.2020.03073

By:

Junkichi Kanda;
Megumi Furukawa;
Nobuo Izumo;
Taketoshi Shimakura;
Noriaki Yamamoto;
Takahashi, Hideaki E.;
Hiroyuki Wakabayashi

Publication type:

Article

The roles of dipeptidyl peptidase-4 inhibitors in prognosis of COVID-19 infection in patients with type 2 diabetes mellitus.

Published in:

Journal of Research in Medical Sciences, 2022, v. 27, n. 8, p. 62, doi. 10.4103/jrms.jrms_71_22

By:

Sadidi, Mohammad;
Zare, Ahad;
Nasrollahzadehsabet, Mehrdad;
Dastan, Farzaneh;
Mosadegh Khah, Ali;
Jafari Asheyani, Milad

Publication type:

Article

The Renoprotective Effect of Linagliptin in Type 2 Diabetic Patients with Severely Increased Albuminuria.

Published in:

2021

By:

Moeinzadeh, Firouzeh;
Iraj, Bijan;
Mortazavi, Mojgan;
Ramezani, Pourya;
Moeinzadeh, Firoozeh;
Ramezani, Pouria

Publication type:

journal article

Micellar Thin Layer Chromatography and Computer-Aided Analysis of Empagliflozin, Linagliptin and Metformin HCl Ternary Mixture.

Published in:

Journal of Chromatographic Science, 2022, v. 60, n. 10, p. 946, doi. 10.1093/chromsci/bmac008

By:

Abbas, Noha S;
Mohamed, Yahya Abduh Salim;
Derayea, Sayed M;
Omar, Mahmoud A;
Saleh, Gamal A

Publication type:

Article